Afexa Life Sciences Inc. (T.FXA) hit a new 52-week high of 88 cents Monday. Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX), announced today that it intends to raise its takeover offer for Afexa Life Sciences Inc. of Edmonton, to $0.85 per common share, an increase of 20% from $0.71 originally offered under an agreement announced on August 30.
The increased offer is subject to Afexa's agreement to certain amendments to the support agreement, including a reduction in the minimum tender condition, which Valeant hopes to resolve in the coming days.
Tim Hortons Inc. (T.THI) hit a new 52-week high of $48.91 Monday. No news announcements today
Horizons BetaPro COMEX Silver Inverse ETF (T.HIZ) hit a new 52-week high of $11.62 Monday. No news announcements today
Related Stories
